Joilna Alves da Silva

Joilna Alves da Silva

Auto-generated profile, based on publicly available information

Joilna Alves da Silva

Program in Natural Sciences, Natural Products Chemistry Laboratory, State University of Ceará, Fortaleza, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in Natural Products and Bioprospecting
Verified
Journal Article
Open access
PDF file
JRJoana Ribeiro
Joana Ribeiro
HAHenrique Araújo-Silva
Henrique Araújo-Silva
MFMário Fernandes
Mário Fernandes
JSJoilna Alves da Silva
Joilna Alves da Silva
FPFrancisco das Chagas Lima Pinto
Francisco das Chagas Lima Pinto
Andreia Castro GomesAndreia Castro Gomes
Andreia Castro Gomes
According to The World Alzheimer Report 2023 by Alzheimer’s Disease International (ADI) estimates that 33 to 38.5 million people worldwide suffer from Alzheimer’s Disease (AD). A crucial hallmark associated with this disease is associated with the deficiency of the brain neurotransmitter acetylcholine, due to an affected acetylcholinesterase (AChE) activity. Marine organisms synthesize several classes of compounds, some of which exhibit significant AChE inhibition, such as petrosamine, a coloured pyridoacridine alkaloid. The aim of this work was to characterize the activity of petrosamine isolated for the first time from a Brazilian marine sponge, using two neurotoxicity models with aluminium chloride, as exposure to aluminium is associated with the development of neurodegenerative diseases. The in vitro model was based in a neuroblastoma cell line and the in vivo model exploited the potential of zebrafish (Danio rerio) embryos in mimicking hallmarks of AD. To our knowledge, this is the first report on petrosamine’s activity over these parameters, either in vitro or in vivo, in order to characterize its full potential for tackling neurotoxicity. Graphical Abstract